Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …

Background Antitachycardia pacing (ATP) is routinely used to terminate ventricular
tachyarrhythmias (VTs). However, little guidance exists on the most effective programming of …

Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …

Programming ATP for ICD Patients. Objectives: The PROVE trial was designed to determine
if antitachycardia pacing (ATP) is clinically beneficial for primary prevention in patients who …

Abstract Purpose of Review Implantable cardioverter-defibrillator (ICD) shocks, whether
appropriate or inappropriate, are associated with significant morbidity and mortality. Anti …

Background In Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate
Therapy (MADIT-RIT), high-rate cutoff (arm B) and delayed therapy (arm C) reduced the risk …

Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …

In clinical practice, most implantable-cardioverter defibrillators (ICDs) are implanted for
primary prevention of sudden death, and the most common therapy ICDs deliver is …

The incorporation of antitachycardia pacing (ATP) into implantable cardioverter defibrillators
(ICDs) has provided a better tolerated alternative to shocks. ATP has been shown to be …

This editorial refers to 'Safety and efficacy of programming a high number of antitachycardia
pacing attempts for fast ventricular tachycardia: a prospective study'by RP Martins et al., on …